# Keros Therapeutics, Inc.: Form DEF 14A, filed Apr 22, 2026

- Company: [Keros Therapeutics, Inc.](/companies/kros.md) (CIK 1664710)
- Form: DEF 14A
- Filed: 2026-04-22
- Accepted by EDGAR: Apr 22, 2026, 16:01 ET
- Period: 2026-06-03
- Accession: 0001104659-26-046791
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1664710/000110465926046791/tm261345-1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1664710/000110465926046791/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1664710/000110465926046791/tm261345-1_def14a.htm

Filed Apr 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-046791. Last ingested by Listed: Nov 5, 2026, 17:32 ET. No prices; not investment advice.